Browsing by Author "Chi, Yueh-Yun"
-
Alveolar Rhabdomyosarcoma with Regional Nodal Involvement: Results of a Combined Analysis from Two Cooperative Groups
Rodeberg, David A.; Gallego, Soledad; Chi, Yueh-Yun; De Salvo, Gian Luca; Li, Minjie; Merks, Johannes H.M.; van Scheltinga, Sheila Terwisscha; Mascarenhas, Leo; Orbach, Daniel; Jenney, Meriel; Jenney, Meriel; Million, Lynn; Minard-Colin, Veronique; Wolden, Suzanne; Zanetti, Ilaria; Parham, David M.; Mandeville, Henry; Venkatramani, Rajkumar; Bisogno, Gianni; Hawkins, Douglas S. (2021-03) -
Benefit of Delayed Primary Excision in Rhabdomyosarcoma: A Report from the Children’s Oncology Group (COG)
Rodeberg, David A.; Lautz, Timothy B.; Chi, Yueh-Yun; Li, Minjie; Wolden, Suzanne L.; Casey, Dana L.; Routh, Jonathan C.; Granberg, Candace F.; Binite, Odion; Rudzinski, Erin R.; Hawkins, Douglas S.; Venkatramani, Rajkumar (2021-01-15) -
Metabolic Response as Assessed by 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography Does Not Predict Outcome in Patients with Intermediate- or High-Risk Rhabdomyosarcoma: A Report from the Children's Oncology Group Soft Tissue Sarcoma Committee
Harrison, Douglas J.; Chi, Yueh-Yun; Tian, Jing; Hingorani, Pooja; Mascarenhas, Leo; McCowage, Geoffrey B.; Weigel, Brenda J.; Venkatramani, Rajkumar; Wolden, Suzanne L.; Yock, Torunn I.; Rodeberg, David A.; Hayes-Jordan, Andrea A.; Teot, Lisa A.; Spunt, Sheri L.; Meyer, William H.; Hawkins, Douglas S.; Shulki, Barry L.; Parisi, Marguerite T. (2021) -
Refinement of risk stratification for childhood rhabdomyosarcoma using FOXO1 fusion status in addition to established clinical outcome predictors: A report from the Children's Oncology Group
Hibbitts, Emily; Chi, Yueh-Yun; Hawkins, Douglas S.; Barr, Frederic G.; Bradley, Julie A.; Dasgupta, Roshni; Meyer, William H.; Rodeberg, David A.; Rudzinski, Erin R.; Spunt, Sheri L.; Skapek, Stephen X.; Wolden, Suzanne L.; Arndt, Carola A. S. (2019-08-06)Background: Previous studies of the prognostic importance of FOXO1 fusion status in patients with rhabdomyosarcoma (RMS) have had conflicting results. We re‐examined risk stratification by adding FOXO1 status to traditional ...